IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 61 - 80 of 1042 stories.
December 13, 2013
Aurobindo Pharma (Hyderabad) said today that it has received final approval from the FDA to manufacture and market duloxetine hydrochloride delayed-release capsules 20, 30 and 60 mg...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-receives-FDA-approval-for-generic-Cymbalta_57388.html
December 13, 2013
Handok (Seoul) announced today that it has agreed to buy the pharmaceuticals business of Korea’s leading cosmetics company Amore Pacific (Seoul). Handok agreed to pay 57.5...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Handok-buys-Amore-Pacifics-pharmaceuticals-business_57383.html
December 13, 2013
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), reports an 88.2% fall in operating profits for its fiscal fourth quarter ended 30...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-reports-fall-in-profits-and-sales_57378.html
December 12, 2013
Sun Pharmaceutical Industries (Mumbai) and Lupin (Mumbai), two leading pharma producers for the global markets, announced today that their US subsidiaries have gained FDA approvals for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sun-Pharma-and-Lupin-receive-FDA-approvals-for-generic-Cymbalta_57312.html
December 12, 2013
Shasun Pharmaceuticals (Chennai, India), a leading global supplier of intermediates, active pharma ingredients (APIs) and formulations, announced today that its board of directors has...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Shasun-Pharmaceuticals-to-sell-Vizag-plant_57311.html
December 12, 2013
ScinoPharm (Tainan, Taiwan) says that it has completed the construction of a new facility at Changshu, China, and the new site includes a multipurpose active pharmaceutical ingredient...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-opens-API-plant-in-Changshu-plans-to-expand-site_57300.html
December 10, 2013
Celon Laboratories (Hyderabad, India) said on Monday that it has entered into an agreement with Aurobindo Pharma (Hyderabad) to form a joint venture to develop, manufacture, and sell...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-and-Celon-Laboratories-form-generics-JV-to-cater-US-and-Europe_57238.html
December 10, 2013
The Excipact Association, a project of the IPEC Federation (Brussels), says it has signed an agreement with DQS (Frankfurt), an internationally recognized certification body, for the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Excipact-signs-deal-with-DQS-for-audits-of-pharmaceutical-excipient-suppliers_57228.html
December 10, 2013
PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PCI-Synthesis-Increased-regulatory-scrutiny-wage-inflations-in-India-and-China-to-impact-industry-in-2014_57224.html
December 10, 2013
PCI Synthesis: Increased regulatory scrutiny, wage inflation in India and China, to impact industry in 2014 PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-10-December-2013_57229.html
December 9, 2013
Nuevolution (Copenhagen, Denmark), a small molecule lead discovery company, says it has appointed Tom Berkien as chief business officer, effective 1 January. Berkien will lead...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Nuevolution-appoints-Berkien-as-chief-business-officer_57187.html
December 4, 2013
Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs); and AAIPharma Services (Wilmington, NC), a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambridge-Major-and-AAIPharma-appoint-CFO-of-merged-company_57069.html
December 3, 2013
Merck KGaA eyes pharma acquisitions in the US Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-December-2013_57045.html
December 2, 2013
KKR, a leading global investment firm, says it will acquire a minority stake in Gland Pharma (Hyderabad, India), a leading Indian pure-play generic injectables pharmaceutical products...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/KKR-buys-stake-in-Indian-firm-Gland-Pharma-for-$200-million_57016.html
December 2, 2013
Glenmark Pharmaceuticals (Mumbai, India) says it has appointed Philip Gioia as president/North America and global active pharmaceutical ingredients (APIs). Gioia will be based at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Glenmark-appoints-head-of-APIs-and-North-America-operations_57015.html
November 26, 2013
Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-eyes-pharma-acquisitions-in-the-US-strengthens-ties-with-Israeli-firms_56959.html
November 26, 2013
Johnson Matthey’s fine chemicals division reports rise in sales The fine chemicals division of Johnson Matthey (London), which comprises the company's active pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-26-November-2013_56955.html
November 21, 2013
Johnson Matthey (London) reported £174.3 million ($281.1 million) in profit for its fiscal first half ended 30 September 2013, an increase of about 22% on the same period the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Matthey-reports-22-percent-increase-in-first-half-profits_56849.html
November 19, 2013
DSM and JLL Partners (New York), a middle-market private equity firm, will create a new company, which will be a leading, global contract development and manufacturing organization...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-and-JLL-form-$2-billion-pharma-services-firm-by-merging-DSM-Pharmaceutical-Products-with-Patheon_56770.html
November 19, 2013
DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon DSM and JLL Partners (New York), a middle-market private equity firm, will create a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-19-November-2013_56774.html
Pages: « Previous  1 2 3 [4] 5 6 7 8 9 10 11 12 13 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa